vs
Side-by-side financial comparison of Acadian Asset Management Inc. (AAMI) and Vericel Corp (VCEL). Click either name above to swap in a different company.
Acadian Asset Management Inc. is the larger business by last-quarter revenue ($172.2M vs $92.9M, roughly 1.9× Vericel Corp). Vericel Corp runs the higher net margin — 25.0% vs 20.2%, a 4.9% gap on every dollar of revenue. On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs 2.6%). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs 27.6%).
United Asset Management was an American holding company headquartered in Boston, Massachusetts.
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
AAMI vs VCEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $172.2M | $92.9M |
| Net Profit | $34.7M | $23.2M |
| Gross Margin | — | 78.7% |
| Operating Margin | 33.3% | 24.1% |
| Net Margin | 20.2% | 25.0% |
| Revenue YoY | 2.6% | 23.3% |
| Net Profit YoY | -18.4% | 17.3% |
| EPS (diluted) | $0.97 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $172.2M | $92.9M | ||
| Q3 25 | $144.2M | $67.5M | ||
| Q2 25 | $127.4M | $63.2M | ||
| Q1 25 | $119.9M | $52.6M | ||
| Q4 24 | $167.8M | $75.4M | ||
| Q3 24 | $123.1M | $57.9M | ||
| Q2 24 | $109.0M | $52.7M | ||
| Q1 24 | $105.7M | $51.3M |
| Q4 25 | $34.7M | $23.2M | ||
| Q3 25 | $15.1M | $5.1M | ||
| Q2 25 | $10.1M | $-553.0K | ||
| Q1 25 | $20.1M | $-11.2M | ||
| Q4 24 | $42.5M | $19.8M | ||
| Q3 24 | $16.9M | $-901.0K | ||
| Q2 24 | $11.0M | $-4.7M | ||
| Q1 24 | $14.6M | $-3.9M |
| Q4 25 | — | 78.7% | ||
| Q3 25 | — | 73.5% | ||
| Q2 25 | — | 73.7% | ||
| Q1 25 | — | 69.0% | ||
| Q4 24 | — | 77.6% | ||
| Q3 24 | — | 71.9% | ||
| Q2 24 | — | 69.5% | ||
| Q1 24 | — | 68.9% |
| Q4 25 | 33.3% | 24.1% | ||
| Q3 25 | 18.4% | 5.1% | ||
| Q2 25 | 12.7% | -3.2% | ||
| Q1 25 | 26.6% | -24.3% | ||
| Q4 24 | 38.7% | 24.5% | ||
| Q3 24 | 21.9% | -4.3% | ||
| Q2 24 | 18.9% | -11.5% | ||
| Q1 24 | 21.7% | -10.7% |
| Q4 25 | 20.2% | 25.0% | ||
| Q3 25 | 10.5% | 7.5% | ||
| Q2 25 | 7.9% | -0.9% | ||
| Q1 25 | 16.8% | -21.4% | ||
| Q4 24 | 25.3% | 26.3% | ||
| Q3 24 | 13.7% | -1.6% | ||
| Q2 24 | 10.1% | -8.9% | ||
| Q1 24 | 13.8% | -7.5% |
| Q4 25 | $0.97 | $0.46 | ||
| Q3 25 | $0.42 | $0.10 | ||
| Q2 25 | $0.28 | $-0.01 | ||
| Q1 25 | $0.54 | $-0.23 | ||
| Q4 24 | $1.11 | $0.40 | ||
| Q3 24 | $0.45 | $-0.02 | ||
| Q2 24 | $0.29 | $-0.10 | ||
| Q1 24 | $0.37 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $137.5M |
| Total DebtLower is stronger | $200.0M | — |
| Stockholders' EquityBook value | — | $354.6M |
| Total Assets | $677.0M | $488.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $137.5M | ||
| Q3 25 | — | $135.4M | ||
| Q2 25 | — | $116.9M | ||
| Q1 25 | — | $112.9M | ||
| Q4 24 | — | $116.2M | ||
| Q3 24 | — | $101.7M | ||
| Q2 24 | — | $102.5M | ||
| Q1 24 | — | $110.6M |
| Q4 25 | $200.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $275.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $354.6M | ||
| Q3 25 | — | $321.9M | ||
| Q2 25 | — | $306.8M | ||
| Q1 25 | — | $295.5M | ||
| Q4 24 | — | $292.0M | ||
| Q3 24 | — | $257.5M | ||
| Q2 24 | — | $243.0M | ||
| Q1 24 | — | $233.9M |
| Q4 25 | $677.0M | $488.0M | ||
| Q3 25 | $751.4M | $453.3M | ||
| Q2 25 | $672.3M | $435.6M | ||
| Q1 25 | $677.3M | $424.6M | ||
| Q4 24 | $703.2M | $432.7M | ||
| Q3 24 | $555.2M | $390.4M | ||
| Q2 24 | $533.1M | $376.8M | ||
| Q1 24 | $544.9M | $356.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.4M | $15.0M |
| Free Cash FlowOCF − Capex | — | $12.8M |
| FCF MarginFCF / Revenue | — | 13.8% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | -0.07× | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | — | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.4M | $15.0M | ||
| Q3 25 | $-23.9M | $22.1M | ||
| Q2 25 | $61.6M | $8.2M | ||
| Q1 25 | $-48.8M | $6.6M | ||
| Q4 24 | $55.8M | $22.2M | ||
| Q3 24 | $69.6M | $10.2M | ||
| Q2 24 | $45.7M | $18.5M | ||
| Q1 24 | $-40.4M | $7.2M |
| Q4 25 | — | $12.8M | ||
| Q3 25 | — | $19.5M | ||
| Q2 25 | — | $81.0K | ||
| Q1 25 | — | $-7.6M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | — | $-9.2M | ||
| Q2 24 | — | $1.8M | ||
| Q1 24 | — | $-6.8M |
| Q4 25 | — | 13.8% | ||
| Q3 25 | — | 28.8% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | -14.5% | ||
| Q4 24 | — | 11.2% | ||
| Q3 24 | — | -15.9% | ||
| Q2 24 | — | 3.4% | ||
| Q1 24 | — | -13.3% |
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 3.9% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 27.0% | ||
| Q4 24 | — | 18.3% | ||
| Q3 24 | — | 33.5% | ||
| Q2 24 | — | 31.8% | ||
| Q1 24 | — | 27.3% |
| Q4 25 | -0.07× | 0.65× | ||
| Q3 25 | -1.58× | 4.35× | ||
| Q2 25 | 6.10× | — | ||
| Q1 25 | -2.43× | — | ||
| Q4 24 | 1.31× | 1.12× | ||
| Q3 24 | 4.12× | — | ||
| Q2 24 | 4.15× | — | ||
| Q1 24 | -2.77× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AAMI
Segment breakdown not available.
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
